-Reuters
Cosmos Health Enters Into Binding Letter Of Intent For The Acquisition Of Docpharm GmbH., An Established German Pharmaceutical Distributor; Expected To Boost Annual Revenue By ~€32M, Or 70%, By The End Of 2025 Vs FY22
Cosmos Health Inc. ("Cosmos Health" or "the Company") (NASDAQ:COSM), a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded